Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000130

Director sold 558 shares at $20.72 ($11,560)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Friedberg Ezra M Director 2026-10-02 Sale 10b5-1 −558 $20.72 $11,560 80,484 D: show line 1 in the form
Open-market sales · 558 sh · avg $20.72 · $11,560
Loading xslF345X06/wk-form4_1791323632.xml…